Engineers Gate Manager’s Caris Life Sciences CAI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-102,757
Closed -$1.84M 2716
2026
Q1
$1.84M Buy
102,757
+31,354
+44% +$685K 0.02% 752
2025
Q4
$1.93M Buy
71,403
+49,375
+224% +$1.39M 0.02% 728
2025
Q3
$666K Buy
+22,028
New +$702K 0.01% 1380

Other funds holding CAI

Engineers Gate Manager's CAI Position: Q2 2026 in Review

Engineers Gate Manager sold out of Caris Life Sciences (CAI) in Q2 2026, closing a stake of 102,757 shares — an estimated $1.84M sold.

Engineers Gate Manager first reported a position in CAI in Q3 2025 and held it in 3 quarters. The position peaked at $1.93M in Q4 2025. 246 funds tracked by Wall St. Rank hold CAI as of Q2 2026.

  • Engineers Gate Manager reported no remaining Caris Life Sciences position as of Q2 2026 after selling out during the quarter.
  • Engineers Gate Manager sold 102,757 Caris Life Sciences shares in Q2 2026, an estimated $1.84M.
  • Engineers Gate Manager first reported a position in Caris Life Sciences in Q3 2025 and held it in 3 quarters.
  • Engineers Gate Manager's Caris Life Sciences position peaked at $1.93M in Q4 2025.
  • 246 funds tracked by Wall St. Rank held Caris Life Sciences as of Q2 2026.

Based on Engineers Gate Manager's 13F filing for Q2 2026, filed 14 Aug 2026.